CrushSCI.com
Journal Selection & Manuscript Polishing Services
CURRENT TREATMENT OPTIONS IN ONCOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

CURRENT TREATMENT OPTIONS IN ONCOLOGY

Springer SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q1
66Average days
59Median days
12Fastest days
131Longest days
852025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

131 days

Antibody-Drug Conjugates in the Treatment of Esophageal Cancer

AuthorsDapeng Wu; Wei Chen; Qi Zhao; Wenjing Zhu; Jian Xu

Affiliations1. Department of Oncology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China; 2. Department of Oncology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China; 3. College of Pharmacy, Dalian Medical University, Dalian, China; 4. Medical Research Department, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China

Source PDF DOI Publisher page
111 days

Combined Anti-PD-1/PD-L1 and Anti-angiogenic Therapy: An Emerging Direction for Future NSCLC Treatment

AuthorsMingtai Li; Zhiqing Wu; Xin Zheng; Yanhong Zhu; Yuxuan Wu; Jiaxin He; Xin Wu; Jingtong Xu; Yinyin Qin

Affiliations1. State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; 2. School of Public Health, Sun Yat-sen University, Guangzhou, China; 3. First Clinical School, Guangzhou Medical University, Guangzhou, China; 4. Nanshan School, Guangzhou Medical University, Guangzhou, China

Source PDF DOI Publisher page
27 days

Current Treatment Options Guided by Molecular Classification in Endometrial Cancer

AuthorsQingyu Zhou; Wenxiu Fu; Qianshuo Zhang; Xiaolu Tian; Zhengmao Zhang

Affiliations1. Department of Gynecology, Hebei Medical University Fourth Hospital, Shijiazhuang, China

Source PDF DOI Publisher page
12 days

Optimising Clinical Outcomes Following R1 Resection in Soft Tissue Sarcoma: An Evidence-Based Approach

AuthorsPiotr Remiszewski; Marcin Rosiński; Adam S. Sukiennik; Paulina Chmiel; Anna Szumera-Ciećkiewicz; Piotr Rutkowski; Anna M. Czarnecka

Affiliations1. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland; 2. Medical Faculty, Medical University of Warsaw, Warsaw, Poland; 3. Outpatient Chemotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; 4. Biobank, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; 5. Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland

Source PDF DOI Publisher page
34 days

Local Recurrence After Pancreatic Cancer Resection: A Multidisciplinary Review of Risk Factors and Potential Causes, Diagnostic Innovations, Emerging Therapeutic Frontiers, and Prevention Strategies

AuthorsRui Wang; Senhao Liu; Junjie Ding; Yunwei Sun; Jin Zhou; Bing Peng; Zhong Wu

Affiliations1. Division of Pancreatic Surgery, Department of General Surgery, Laboratory of Pancreatic Cancer, West China Hospital of Sichuan University, Chengdu, P.R. China; 2. Department of Radiology, West China Tianfu Hospital, Sichuan University, Chengdu, P.R. China; 3. Division of Liver Surgery, Department of General Surgery, West China Hospital of Sichuan University, Chengdu, P.R. China

Source PDF DOI Publisher page
45 days

Dedifferentiated Chondrosarcoma: Current Advances and Future Perspectives

AuthorsRebecca Ibrahim; Julien Vibert; Tania Moussa; Carine Ngo; Matthieu Faron; Benjamin Verret; Caterina Zanella; Rabih Mikhael; Elie Tabet; Antonin Lévy; Charles Honoré; Cécile Le Péchoux; Ratislav Bahleda; Axel Le Cesne; Tarek Assi

Affiliations1. Department of Cancer Medicine, Gustave Roussy, Villejuif, France; 2. Radiology Department, Gustave Roussy, Université Paris Saclay, Villejuif, France; 3. Department of Neurology, Massachussets General HospitalHarvard Medical School, Boston, USA

Source PDF DOI Publisher page
26 days

Current Treatment Options and Emerging Technologies for Pelvic Bone Tumors: From Limb Salvage to Precision Oncology

AuthorsYichen Liu; Ziang Zhang; Chaoyang Jiang; Ke Jia; Yue Shen; Hongzhi Hu; Baichuan Wang

Affiliations1. Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Source PDF DOI Publisher page
74 days

The Future is Local: the Role of Decentralised Clinical Trials in Patients with Advanced Cancer Receiving Palliative Care

AuthorsClaire Stokes; Phillip Good

Affiliations1. Mater Hospital Brisbane, South Brisbane, Australia; 2. Mater Research Institute, University of Queensland, Brisbane, Australia; 3. St Vincent’s Private Hospital Brisbane, Kangaroo Point, Australia; 4. Centre for Palliative Care Research and Education, RBWH, Herston, Australia

Source PDF DOI Publisher page
127 days

Role of Troponins in CardioOncology

AuthorsJakub Homotnik; Sabina Mędrek; Kasper Rolek; Magdalena Zaborowska-Szmit; Sebastian Szmit

Affiliations1. Department of Cardiology and Cardio-Oncology Unit, Subcarpathian Oncological Center, Brzozow, Poland; 2. Department of Cardio-Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland; 3. Department of Lung Cancer and Thoracic Tumours, Maria Skłodowska- Curie National Research Institute of Oncology, Warsaw, Poland; 4. Cardio-Oncology Unit, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Source PDF DOI Publisher page
73 days

Telemedicine and Virtual Reality Technologies in Pain Management for Cancer Patients: A Structured Narrative Review

AuthorsSevda Uzun; Döne Günay

Affiliations1. Department of Nursing, Department of Psychiatric Nursing, Kırşehir Ahi Evran University Faculty of Health Sciences, Kırşehir, Turkey; 2. Sivas Provincial Directorate of Health, Sivas, Turkey

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.